Dr. Tolulope Bakare, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1400 N Coit Rd Ste 302, Mckinney, TX 75071 Phone: 469-722-5700 Fax: 833-449-4351 |
Evan Anthony Mulloy, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1400 N Coit Rd Ste 302, Mckinney, TX 75071 Phone: 469-722-5700 Fax: 833-449-4351 |
Aaron Krug, M.D. Urology Medicare: Medicare Enrolled Practice Location: 5220 W University Dr Ste 210, Mckinney, TX 75071 Phone: 214-691-1902 Fax: 214-987-1845 |
Dr. Mark A Norris, MD Urology Medicare: Medicare Enrolled Practice Location: 5236 W. University Dr., Suite 1000, Mckinney, TX 75071 Phone: 972-542-8609 Fax: 972-542-8613 |
Dr. Jared Darrell Stringer, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4501 Medical Center Dr, Suite 100, Mckinney, TX 75069 Phone: 972-548-8195 Fax: 972-548-8866 |
News Archive
Patients affected by Parkinson's disease may experience, in addition to the more obvious motor symptoms (such as tremors and stiffness), difficulties recognizing emotions in the facial expressions and speech prosody (intonation) of other people. A number of investigations have shown that even deep brain stimulation, a treatment that has become widely used in recent years, may cause similar disorders.
UNICEF Executive Director Anthony Lake said Wednesday "that a more transparent and competitive market will lead to savings of more than $20 million over the next 12 months through a price reduction of 20 percent for bednets that protect people from malaria," a UNICEF press release reports.
PLC Systems Inc., a company focused on innovative medical device technologies, today announced that it had received approval from the Brazilian government to market its innovative RenalGuard System in that country.
Antibiotic use on people or pets, and use of biocidal cleaning products such as bleach, are associated with multidrug resistance in methicillin-resistant Staphylococcus aureus (MRSA) in the home.
Akonni Biosystems, a molecular diagnostics company that develops, manufactures, and plans to market sophisticated genetic testing devices for diagnosing complex infectious and human diseases, today announced receipt of a nearly $500,000 Phase III Grant from the National Institutes of Justice (NIJ).
› Verified 3 days ago